Navigation Links
Simcere Pharmaceutical Group Announces Participation in Brean Murray Carret & Co.'s Fourth Investor Tour of China
Date:4/1/2008

NANJING, China, April 1, 2008 /Xinhua-PRNewswire/ -- Simcere Pharmaceutical Group (NYSE: SCR), a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endu in China, today announced its participation in Brean Murray, Carret & Co.'s Fourth Investor Tour of China being held from Monday, March 31, 2008 to Friday, April 4, 2008 in Beijing, Shenzhen and Shanghai.

Simcere's Chief Financial Officer Frank Zhao, will present in the Aries Boardroom of the Grand Hyatt Shanghai on Friday April 4, 2008 at 11:15 am Beijing/Hong Kong time.

A copy of Simcere's investor presentation will be available on the investor relations portion of the Company's Web site, located at http://www.simcere.com .

About Simcere Pharmaceutical Group

Simcere Pharmaceutical Group (NYSE:SCR, Simcere) is a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endu in the rapidly growing China market. In recent years, Simcere has focused its strategy on the development of first- to-market generic and innovative pharmaceuticals, and has introduced a first- to-market generic stroke management medication under the brand name Bicun and an innovative anti-cancer medication under the brand name Endu. Simcere currently manufactures and sells more than 50 pharmaceutical products including antibiotics, anti-cancer medication and stroke managem
'/>"/>

SOURCE Simcere Pharmaceutical Group
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2007 Results
2. Simcere Pharmaceutical Group to Announce Fourth Quarter 2007 Earnings on Tuesday, March 4, 2008
3. Simcere Pharmaceutical Group Reports Third Quarter 2007 Results
4. Simcere Pharmaceutical Group Acquires a 51% Stake in Boda Pharmaceutical Co., Ltd.
5. Benda Pharmaceutical Reports Fourth Quarter and Full Year 2007 Financial Results
6. Pharmaceutical Strategic Initiatives Adds Anne Sexton, MD, MS to Management Team
7. Alseres Pharmaceuticals, Inc. Complies With NASDAQ Rule Regarding Recently Filed 10-K
8. Caraco Pharmaceutical Laboratories Ltd. To Market Generic Ethyol(R)
9. China Shenghuo Pharmaceutical Holdings, Inc. Schedules Conference Call to Discuss FY 2007 Results
10. Barr Pharmaceuticals, Inc. Executive Bios
11. Biotest Pharmaceuticals Corporation Responds to Orphan Drug Act Announcement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...image-guided treatment is a safe and precise metho...om the body, according to the first report on "sel...licted foreign body insertion in adolescents. The ...ting of the Radiological Society of North America ... to be the first to detect self-embedding disorder...
(Date:12/2/2008)...ewswire/ -- Research scientists using a,novel, ha...I) have found that,chronic stroke patients can be...day at the annual meeting of the Radiological Soci...udy using fMRI to map the brain in order to track,...at the brain has the ability to regain function th...
(Date:12/2/2008)...c. 1 diaDexus, Inc. today,announc...ated format of the,PLAC Test for Lp-PLA2. This au...nning on a wide range of clinical chemistry analyz... Administration (FDA) in December 2007. diaDexus a... PLAC Test to Europe. , The PLAC Test is th...
(Date:12/2/2008)...re/ -- At a symposium today hosted by Johns,Hopk...nce researchers presented,the latest research in ...g the,science into technology to improve lives. H...sented evidence that cognitive intervention develo...ty, the brain,s ability to,reorganize itself thro...
Breaking Medicine News(10 mins):Health News:Radiologists diagnose and treat self-embedding disorder in teens 2Health News:Robotic Technology Improves Stroke Rehabilitation 2Health News:Robotic Technology Improves Stroke Rehabilitation 3Health News:diaDexus Receives CE Mark Certification for the PLAC(R) Test 2Health News:Posit Science Invited to Speak at Johns Hopkins University About Cutting Edge Cognitive Training Interventions 2
...ssociation between the level of sex hormones and a...eptors for the female hormones estrogen and proges...eptors are the eyes and ears of the cells, receivi... hormones. Estrogen and progesterone stimulate gro...
...acupuncture can help those suffering from arthriti...rrent multi-location trial included 570 patients a...articipants were placed in three groups. One hundr...ure, 191 underwent sham acupuncture, and 189 follo...
...ns are currently performed among the diabetic popu... blood vessels in the retinas of about 900 diabeti... before age 30. All were followed for 20 years to ...ight relate to subsequent need for an amputation. ...
... of countries where iodine deficiency is a public ... on a new global report on iodine status.// The si...ed well. The number of countries where iodine defi...reduced to 54 in 2003, from 110 in 1993. "Iodine d...
Other Medicine News:Health News:WHO hopes to wipe away Iodine deficiency diseases by 2005 2
(Date:11/28/2008)...re/ -- German biotech company,Partec is expanding...ng and,AIDS patient follow-up diagnostics for dev... 2.5 million patient tests have been performed wit...low" system, supporting already,more than 1 milli...n of the,Partec innovation, the average cost of E...
(Date:11/26/2008)...d intelligent clinical applications take workflow ... , CHICAGO, Ill., Nov. 26 /PRNewswire-FirstCall...thcare ) highlights the ACUSON S2000(TM) Automate...rst multi-use, automated volume breast ultrasound ... Meeting of the Radiological Society of North Amer...
(Date:11/25/2008)...nding statin use broadly in wake of AHA-presented ...wswire/ -- JUPITER, a clinical trial suggesting ro...althy patients with elevated CRP, should not promp...to a national poll directed at health professional... poll conducted by medical news site MedPage Today...
(Date:11/25/2008)...ssess Survival of Patients Receiving Litx versus S...ellular Carcinoma , , BELLEVUE, Wash., Nov....(LSO) today announced the completion of enrollment...ion Therapy(TM) (Litx(TM)) as a treatment for unre...n as hepatoma or primary liver cancer. , , ...
Breaking Medicine Technology:German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2Siemens Introduces New Standard of Care for Breast Ultrasound 2Siemens Introduces New Standard of Care for Breast Ultrasound 3Siemens Introduces New Standard of Care for Breast Ultrasound 4Siemens Introduces New Standard of Care for Breast Ultrasound 5Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4Chemical liberated by leaky gut may allow HIV to infect the brain Einstein scientists find 25520 1Chemical liberated by leaky gut may allow HIV to infect the brain Einstein scientists find 25520 2Chemical liberated by leaky gut may allow HIV to infect the brain Einstein scientists find 25520 3Chemical liberated by leaky gut may allow HIV to infect the brain Einstein scientists find 25520 4Researchers study facial structures brain abnormalities to reveal formula for detection of autism 4511 1Researchers study facial structures brain abnormalities to reveal formula for detection of autism 4511 2Signals from the Atlantic salmon highway 4508 1Signals from the Atlantic salmon highway 4508 2Signals from the Atlantic salmon highway 4508 3Signals from the Atlantic salmon highway 4508 4Medco Announces Research Collaboration with FDA Focused on Personalized Medicine 25512 1Medco Announces Research Collaboration with FDA Focused on Personalized Medicine 25512 2Medco Announces Research Collaboration with FDA Focused on Personalized Medicine 25512 3Medco Announces Research Collaboration with FDA Focused on Personalized Medicine 25512 4
... the Journal of Clinical Oncology -, NEW YORK, Jul...a,Phase II study - which will be published in the ...ncology (JCO) and are now,available as an Early Re...www.jco.org/">www.jco.org - demonstrate that,ixab...ional,compound, has activity in patients with meta...
... TMC125, an Investigational NNRTI,from Tibotec, YA...m two,ongoing Phase 3 studies (DUET-1 and DUET-2) ...h documented non-nucleoside reverse,transcriptase ...stance reached an undetectable viral load (defined...V-1 RNA copies/mL) with,TMC125 (etravirine), Tibot...
Other Medicine Technology:Study Shows Ixabepilone Demonstrated Clear Activity in Patients,with Metastatic Breast Cancer Resistant to Anthracycline, Taxane,and Capecitabine 2Study Shows Ixabepilone Demonstrated Clear Activity in Patients,with Metastatic Breast Cancer Resistant to Anthracycline, Taxane,and Capecitabine 3Study Shows Ixabepilone Demonstrated Clear Activity in Patients,with Metastatic Breast Cancer Resistant to Anthracycline, Taxane,and Capecitabine 4TMC125 Showed Significant Virologic Response at Week 24 in,Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3,Trials 2TMC125 Showed Significant Virologic Response at Week 24 in,Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3,Trials 3TMC125 Showed Significant Virologic Response at Week 24 in,Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3,Trials 4
The inventory system designed for Wholesale Distributors and centralized distribution centers for Optical chains.
...Ordering/Dispensing has gained recognition as the ... lens ordering system. It enables opticians to pla...g SDS electronic communications technology. When u...r 3D frame tracers, lens shapes are automatically ...
... is a complete practice and business management so...ts, opticians and ophthalmologists- It is designed...ally rich and intuitive windows interface with a f...- The multi-user version of this practice and Busi...
The K-4500 automated hematology analyzer offers fast reliable test results of 18-parameter plus 3-histograms, valuable for effective diagnosis.
Medicine Products: